ITGAM and diabetes mellitus: By contrast, targeting antigen to DCIR2+CD11b+ cDC2s induce tolerogenic responses even in this chronic autoimmune environment and stimulation of T cells by DCIR2+ cDC2s can inhibit diabetes development (38).